Skip to main content

Inspection visit

Inspection

ELEVATE CARE NORTHBROOKCMS #1451719 citations on this visit
9 citations recorded

Inspector’s narrative

What the inspector wrote

This survey cited 9 deficiencies. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0759 Ensure medication error rates are not 5 percent or greater. Level of Harm - Minimal harm or potential for actual harm Based on observations, interviews, and record review, the facility failed to administer medications as ordered for 1 (R93) of 5 residents reviewed during medication administration in the sample of 48. There were 27 opportunities with two errors resulting in a 7.41% error rate. Residents Affected - Few Findings include: On 08/12/24 at 09:22 AM Surveyor observed V11 (Licensed Practical Nurse) administering medications on the second floor unit. Surveyor observed V11 (LPN) administering medications to R93. On 08/12/2024 at 01:56 PM Surveyor noticed, while completing medication reconciliation, that V11 (LPN) documented in R93's MAR (Medication Administrator Record) two medications as given whereas surveyor did not observe those medications being given during medication administration task. On 08/12/24 at 02:13 PM Surveyor interviewed V11 (LPN). Surveyor asked if V11 (LPN) gave all medications to R93, V11 (LPN) said, R93 refused two. Surveyor asked if V11 (LPN) followed up with R93 and offered it again, V11 (LPN) said, I will do it right now. Surveyor established that V11 (LPN) signed out both medications as given, V11 (LPN) said, I'm sorry, let me see if R93 wants them now. Surveyor asked what should have been done this morning, upon R93's refusal, V11 (LPN) said, I should have documented it as refused when R93 refused to take two of the medications this morning. On 08/13/24 at 10:17 AM Surveyor interviewed V2 (Director of Nursing) who stated: If a resident refuses a medication, nurse should re-offer the medication in a few minutes and try to find out why the resident doesn't want to take it. The nurse should document the refusal and notify all involved parties, such as doctor and resident representative. Surveyor clarified why is it inappropriate to document that medication was given when, in fact, it was not, V2 (DON) said: The documentation is inaccurate if a nurse signs off medication as it was given but, in fact, it was not given. R93's physician order dated 11/27/2022 reads in part, Tiotropium Bromide Monohydrate Capsule 18 MCG 1 capsule inhale orally one time a day for COPD Rinse mouth with water and spit after administration due at 9:00 AM R93's physician order dated 11/27/2022 reads in part, Wixela Inhub Aerosol Powder Breath Activated 250-50 MCG/DOSE (Fluticasone- Salmeterol) 1 puff inhale orally every 12 hours related to Unspecified Asthma. Rinse mouth with H2O and spit back in cup after use due at 9:00 AM and 9:00 PM R93's MAR (Medication Administration Record) for August 2024 shows both, Tiotropium Bromide Monohydrate Capsule and Wixela Inhub Aerosol Powder documented as given on 08/12/2024 at 9:00 AM by V11 (LPN). (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 5 Event ID: 145171 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 145171 B. Wing A. Building (X3) DATE SURVEY COMPLETED 08/14/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Elevate Care Northbrook 270 Skokie Highway Northbrook, IL 60062 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759 Level of Harm - Minimal harm or potential for actual harm The policy provided by the facility MAC Rx Pharmacy Policies and Procedures Manual dated 10/25/2024 reads in part, Refusals of Medications: 5) Medication refusal must be reported to the prescriber after (XX) number of doses are refused and there must be documentation of prescriber notification of such. Documentation (including electronic): 1) At the end of each medication pass, the person administering the medications reviews the MAR to ensure necessary doses were administered and documented. Residents Affected - Few FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 145171 If continuation sheet Page 2 of 5 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 145171 B. Wing A. Building (X3) DATE SURVEY COMPLETED 08/14/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Elevate Care Northbrook 270 Skokie Highway Northbrook, IL 60062 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, and record review, the facility failed to follow their medication storage policy by not ensuring an insulin vial was properly labeled and stored in accordance with accepted professional practice. This failure affected 6 residents with orders for Lispro (Human) insulin (R97, R105, R124, R146, R187, R193) of 6 residents reviewed for medication label and storage. Findings include: On [DATE] at 11:28 AM, reviewed medication storage and labeling task for 1 east med cart with V14 (Registered Nurse) and observed an opened and unlabeled vial of lispro insulin that was half filled. When asked which resident the insulin vial belonged to, V14 (RN) said he did not know. When asked if the insulin vial was currently being used and if the vial should be stored in the refrigerator when not in use, V14 (RN) said yes. V14 (Registered Nurse) then said the insulin vial should have been properly labeled with the resident's name, dated when opened with the date of expiration indicated to avoid staff administering expired insulin to a resident. Requested list of residents on unit 1 east who receive lispro insulin. V1 (Administrator) provided a list of dated [DATE] that showed the following residents: R97, R105, R124, R146, R187, and R193. Active physician orders reconciled with medication administration records for above listed residents that revealed an active order for lispro that is being administered daily as follows: 1. R97's active physician orders showed order with start date of [DATE] for Humalog Solution 100 unit/ml (Insulin Lispro (Human), inject subcutaneous (under the skin) five times a day for diabetes as per sliding scale: if 0 - 69 = 0 Units Give glucose and notify physician; 70 - 149 = 0 Units; 150 - 199 = 1 Unit; 200 - 249 = 3 Units; 250 - 299 = 5 Units; 300 - 349 = 7 Units; 350 > give 8 units and notify physician. Medication administration records for last 60 days (06/2024 through [DATE]) showed daily administrations of lispro insulin for R97. 2. R105's active physician orders showed order with start date of [DATE] for Humalog Solution 100 unit/ml (Insulin Lispro (Human), inject subcutaneous (under the skin) before meals for per clinical parameters related to diabetes, inject as per sliding scale: if 0 - 69 = 0 Units Give glucose and notify physician; 70 - 149 = 0 Units; 150 - 199 = 1 Unit; 200 - 249 = 2 Units; 250 - 299 = 3 Units; 300 - 349 = 4 Units; 350 > give 5 units and notify physician. Medication administration records for last 60 days (06/2024 through [DATE]) showed daily administrations of lispro insulin for R105 as of start date of [DATE]. 3. R124's active physician orders showed order with start date of [DATE] for Humalog Solution 100 unit/ml (Insulin Lispro (Human), inject subcutaneous (under the skin) before meals and at bedtime, inject as per sliding scale: if 150 - 199 = 1 units; 200 - 249 = 2 units ; 250 - 299 = 3 units; 300 - 349 = 4 units more or = 350 milligram (mg)/deciliter (dl) 5 units call primary medical doctor (PMD) for blood sugar (bs) more than 400 and call PMD. Less than 60 mg/dl call PMD. (continued on next page) FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 145171 If continuation sheet Page 3 of 5 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 145171 B. Wing A. Building (X3) DATE SURVEY COMPLETED 08/14/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Elevate Care Northbrook 270 Skokie Highway Northbrook, IL 60062 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761 Level of Harm - Minimal harm or potential for actual harm Medication administration records for last 60 days (06/2024 through [DATE]) showed daily administrations of lispro insulin for R124. 4. R146's active physician orders showed order with start date of [DATE] for Humalog Solution 100 unit/ml (Insulin Lispro (Human), inject 3 units subcutaneous (under the skin) every 6 hours for diabetes. Residents Affected - Some Medication administration records for last 60 days (06/2024 through [DATE]) showed daily administrations of lispro insulin for R146. 5. R187's active physician orders showed order with start date of [DATE] for Humalog Solution 100 unit/ml (Insulin Lispro (Human), inject subcutaneous (under the skin) before meals and at bedtime for diabetes AND Inject 3 unit subcutaneously before meals and at bedtime related to diabetes, inject as per sliding scale: if 0 - 69 = 0 Units Give glucose and notify physician; 70 - 149 = 0 Units; 150 - 199 = 1 Unit; 200 - 249 = 2 Units; 250 - 299 = 3 Units; 300 - 349 = 4 Units; 350 > give 5 units and notify physician. Medication administration records for last 60 days (06/2024 through [DATE]) showed daily administrations of lispro insulin for R187 as of start date of [DATE]. 6. R193's active physician orders showed order with start date of [DATE] for Insulin Lispro 100 unit/ml solution, inject subcutaneous (under the skin) one time a day with meal related to type 2 diabetes mellitus, inject as per sliding scale: if 150 - 199 = give 1 unit and notify physician; 200 - 249 = give 2 units; 250 - 299 = give 3 units; 300 - 349 = give 4 units; 350 > give 5 units and notify physician. Medication administration records for last 60 days (06/2024 through [DATE]) showed daily administrations of lispro insulin for R193 as of start date of [DATE]. *Noted R193's discontinued order on [DATE] for Insulin Lispro 100 unit/ml solution with start date of [DATE] to inject subcutaneous (under the skin) before meals related to type 2 diabetes mellitus, inject as per sliding scale: if 0 - 69 = give 0 units and notify physician; 70 - 149 = give 0 units; 150 - 199 = give 1 unit; 200 - 249 = give 2 units; 250 - 299 = give 3 units; 300 - 349 = give 4 units; 350> give 5 units and notify physician. Medication administration records for last 60 days (06/2024 through [DATE]) showed daily administrations of lispro insulin for R193 as of start date of [DATE]* On [DATE] at 11:55 AM, V2 (Director of Nursing) said all insulin vials should be dated upon opening and should include residents name and expiration date. Medication storage policy last revised [DATE] reads in part: to ensure proper storage, labeling and expiration dates of medications, biologicals, syringes and needles. Once any medication or biological package in opened, facility should follow manufacturer/supplier guidelines with respect to expiration dates for opened medications. Facility staff should record the date opened on the medication container when the medication has a shortened expiration date once opened. Facility should destroy and reorder medications and biologicals with soiled, illegible, worn, makeshift, incomplete, damaged or missing labels. Facility should ensure that medications and biologicals are stored at their appropriate temperatures according to United States Pharmacopeia guidelines for temperature ranges. (continued on next page) FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 145171 If continuation sheet Page 4 of 5 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 145171 B. Wing A. Building (X3) DATE SURVEY COMPLETED 08/14/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Elevate Care Northbrook 270 Skokie Highway Northbrook, IL 60062 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Vials and Ampules of Injectable Medications policy effective [DATE] reads in part: vials and ampules of injectable medications are used in accordance with the manufacturer's recommendations or the provider pharmacy's directions for storage, use, and disposal. The date opened and the initials of the first person to use the vial are recorded on the multidose vials. Medication in multidose vials may be used until the manufacturer's expiration date/for the length of time allowed by the state law/according to facility policy/ for thirty days. USP <797> guidelines recommend discarding multidose vials at 28 days after opened. Reviewed lispro manufacturer instructions for use after vials have been opened that indicated to store opened vials in the refrigerator or at room temperature up to 86°F (30°C) for up to 28 days and throw away all opened vials after 28 days of use, even if there is insulin left in the vial. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 145171 If continuation sheet Page 5 of 5

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

9 citations recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0759GeneralS&S Dpotential for harm

    F759 - Medication Errors

    Ensure medication error rates are not 5 percent or greater.

  • 0761GeneralS&S Epotential for harm

    F761 - Labeling of Drugs and Biologicals

    Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs.

  • 0222GeneralS&S Epotential for harm

    Add doors in an exit area that do not require the use of a key from the exit side unless in case of special locking arrangements.

  • 0225GeneralS&S Epotential for harm

    Have stairways and smokeproof enclosures used as exits that meet safety requirements.

  • 0353GeneralS&S Epotential for harm

    Inspect, test, and maintain automatic sprinkler systems.

  • 0362GeneralS&S Epotential for harm

    Ensure that corridors are separated from use areas by walls constructed to limit the passage of smoke.

  • 0363GeneralS&S Epotential for harm

    Install corridor and hallway doors that block smoke.

  • 0372GeneralS&S Epotential for harm

    Ensure smoke barriers are constructed to a 1 hour fire resistance rating.

  • 0374GeneralS&S Epotential for harm

    Install smoke barrier doors that can resist smoke for at least 20 minutes.

FAQ · About this visit

Common questions about this visit

What happened during the August 14, 2024 survey of ELEVATE CARE NORTHBROOK?

This was a inspection survey of ELEVATE CARE NORTHBROOK on August 14, 2024. The surveyor cited 9 deficiencies, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at ELEVATE CARE NORTHBROOK on August 14, 2024?

Yes, 9 deficiencies were cited, each with a CMS Scope and Severity grade. The first was: "Ensure medication error rates are not 5 percent or greater."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

SourceView on CMS Care Compare

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.